Balance Sheet
Accounts PayablesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orthofix Medical (OFIX) Accumulated Expenses (2016 - 2024)

Historic Accumulated Expenses for Orthofix Medical (OFIX) over the last 15 years, with Q4 2024 value amounting to $43.9 million.

  • Orthofix Medical's Accumulated Expenses rose 1306.6% to $43.9 million in Q4 2024 from the same period last year, while for Dec 2024 it was $43.9 million, marking a year-over-year increase of 1306.6%. This contributed to the annual value of $43.9 million for FY2024, which is 1306.6% up from last year.
  • Orthofix Medical's Accumulated Expenses amounted to $43.9 million in Q4 2024, which was up 1306.6% from $38.8 million recorded in Q4 2023.
  • Orthofix Medical's Accumulated Expenses' 5-year high stood at $43.9 million during Q4 2024, with a 5-year trough of $18.5 million in Q4 2022.
  • Its 5-year average for Accumulated Expenses is $29.4 million, with a median of $23.6 million in 2021.
  • Per our database at Business Quant, Orthofix Medical's Accumulated Expenses plummeted by 2131.88% in 2022 and then soared by 10951.92% in 2023.
  • Quarter analysis of 5 years shows Orthofix Medical's Accumulated Expenses stood at $22.4 million in 2020, then increased by 5.32% to $23.6 million in 2021, then decreased by 21.32% to $18.5 million in 2022, then skyrocketed by 109.52% to $38.8 million in 2023, then rose by 13.07% to $43.9 million in 2024.
  • Its Accumulated Expenses stands at $43.9 million for Q4 2024, versus $38.8 million for Q4 2023 and $18.5 million for Q4 2022.